Identification of rift valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assay

Medicine and Dentistry

• High Throughput Screening 100%
• Virus Nucleocapsid 100%
• Rift Valley Fever Virus 100%
• RNA Binding 66%
• Pathogen 33%
• Infection 33%
• Guanine Nucleotide Binding Protein 33%
• Virus Infection 33%
• Antiviral Therapeutics 33%
• Diseases 33%

Pharmacology, Toxicology and Pharmaceutical Science

• High-Throughput Screening 100%
• Nucleocapsid Protein 100%
• Infectious Agent 33%
• Drug Screening 33%
• Pharmaceutical Chemistry 33%
• Lead Compound 33%
• Natural Product 33%
• Antivirus Agent 33%
• Infection 33%
• Guanine Nucleotide Binding Protein 33%
• Virus Infection 33%
• Diseases 33%